This is a competitive renewal of a training program in Developmental Hematology in the Department of Pediatrics at Washington University School of Medicine. The program will provide pediatric physicians (MD's or MD, PhD's) with postdoctoral research experience with the long-term goal of producing independent investigators capable of making important contributions to biomedical research. The program will support one second-year (PGY-4) and one third-year fellow (PGY-5) each year. The trainees will be recruited from the Hematology-Oncology fellowship program in the Department of Pediatrics at Washington University School of Medicine. The fellowship program is comprised of three to four years of training, only two of which will be supported by the T32. The Hematology-Oncology fellowship includes many qualified applicants with backgrounds in hematology research. Trainees will participate in a formal seminar series that includes a discussion of current research in developmental hematology, along with didactic sessions in statistics, design of research, and the ethical conduct of research. Trainees may perform their postdoctoral research in a wide range of laboratories at Washington University, provided the research is relevant to the field of developmental hematology. The Program offers trainees two Pathways. In Pathway A, the emphasis is on basic science genetics/genomics experiences, a core curriculum, and a basic-science curriculum. In Pathway B, the emphasis is on clinical/translational genomic science with patient-oriented laboratory-based experiences, a core curriculum and a clinical investigation, translational medicine or genetics/genomics curriculum. Alan L. Schwartz, MD, PhD, will serve as Program Director. The continued support of this program will help to close the gap between basic developmental biologists and pediatrician clinicians.
This training program is designed to bridge the gap between clinical and basic scientists. The focus of this program is the training of physician scientists in basic and applied research relevant to the causes of hematologic diseases in children. Qualified trainees, both MD's and MD/PhD's, will be selected for their potential to assume academic positions in pediatric departments at major medical schools. The training program compliments existing programs in the Department of Pediatrics designed to enhance training in developmental biology and animal models of disease.
|Monlish, Darlene A; Bhatt, Sima T; Schuettpelz, Laura G (2016) The Role of Toll-Like Receptors in Hematopoietic Malignancies. Front Immunol 7:390|
|Herman, A C; Monlish, D A; Romine, M P et al. (2016) Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms. Blood Cancer J 6:e437|
|Hall, Erin M; Leonard, Jeffrey; Smith, Jodi L et al. (2016) Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy. Pediatr Blood Cancer 63:1431-7|
|Liu, Chang; Duffy, Brian; Bednarski, Jeffrey J et al. (2016) Maternal T-Cell Engraftment Interferes With Human Leukocyte Antigen Typing in Severe Combined Immunodeficiency. Am J Clin Pathol 145:251-7|
|Bednarski, Jeffrey J; Pandey, Ruchi; Schulte, Emily et al. (2016) RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals. J Exp Med 213:209-23|
|Fields, Melanie E; Hoyt-Drazen, Catherine; Abel, Regina et al. (2016) A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell disease. Pediatr Blood Cancer 63:2131-2138|
|Madden, Lisa M; Ngwube, Alexander I; Shenoy, Shalini et al. (2015) Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children. J Pediatr Hematol Oncol 37:e94-e101|
|Fields, Melanie E; Hulbert, Monica L; Chen, Ling et al. (2015) Red blood cell storage duration is not associated with clinical outcomes for acute chest syndrome in children with sickle cell disease. Transfusion 55:2714-21|
|Sengupta, Rajarshi; Barone, Amy; Marasa, Jayne et al. (2015) Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions. Oncotarget 6:18282-92|
|Ngwube, Alexander; Hayashi, Robert J; Murray, Lisa et al. (2015) Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia. Pediatr Blood Cancer 62:1270-6|
Showing the most recent 10 out of 23 publications